mRNA COVID-19 vaccines may improve cancer immunotherapy outcomes

newscientist.com

mRNA COVID-19 vaccines may enhance cancer immunotherapy effectiveness, potentially extending patient survival. An analysis of nearly 1000 cancer patients suggests those vaccinated within 100 days of starting immunotherapy lived nearly twice as long. A clinical trial is planned to confirm these findings. This unexpected benefit stems from mRNA vaccines boosting the immune system's response to tumors, a mechanism that could be further optimized for cancer treatment.


With a significance score of 5.6, this news ranks in the top 0.6% of today's 31797 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: